How big is the Dry Eye Disease Market?

The Dry Eye Disease Market size is expected to reach USD 6.11 billion in 2024 and grow at a CAGR of 4.09% to reach USD 7.46 billion by 2029. Read More

What is the current Dry Eye Disease Market size?

In 2024, the Dry Eye Disease Market size is expected to reach USD 6.11 billion. Read More

Who are the key players in Dry Eye Disease Market?

Santen Pharmaceutical Co. Ltd, OASIS Medical, Alcon Inc., Bausch Health Companies Inc. and AbbVie Inc. (Allergan PLC) are the major companies operating in the Dry Eye Disease Market. Read More

Which is the fastest growing region in Dry Eye Disease Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Dry Eye Disease Market?

In 2024, the North America accounts for the largest market share in Dry Eye Disease Market. Read More

What years does this Dry Eye Disease Market cover, and what was the market size in 2023?

In 2023, the Dry Eye Disease Market size was estimated at USD 5.87 billion. The report covers the Dry Eye Disease Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Dry Eye Disease Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

What are the major factors driving the Dry Eye Disease Market?

The major factors driving the Dry Eye Disease Market are a) Growing demand for convenient and effective treatment options b) Educational campaigns and products aimed at preventing dry eye before symptoms arise can expand the market Read More

Dry Eye Disease Market Report | Industry Analysis, Size & Forecast Overview

Dry Eye Disease Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Dry Eye Syndrome Treatment Market is Segmented by Product (Artificial Tears, Anti-inflammatory Drugs, Punctal Plugs, Secretagogues, and Other Products), Distribution Channel (Hospital Pharmacies, Independent Pharmacies and Drug Stores, and Online Pharmacies), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value in USD million for the above segments.

Dry Eye Disease Industry Overview

The dry eye disease market is fragmented in nature due to the presence of many companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well known. Some major players are AbbVie Inc. (Allergan PLC), AFT Pharmaceuticals, Akorn, Alcon Inc., Bausch Health Companies Inc., Horus Pharma, Johnson & Johnson, Mitotech, Novaliq GmbH, OASIS Medical, Otsuka Pharmaceutical Co. Ltd, Prestige Consumer Healthcare, Santen Pharmaceutical Co. Ltd, Sentiss Pharma Pvt. Ltd, Sun Pharmaceutical Industries Ltd, and VISUfarma.